valrubicin
Selected indexed studies
- Valrubicin. (Drugs Aging, 1999) [PMID:10459733]
- Valrubicin. (, 2006) [PMID:40127366]
- Valrubicin in refractory non-muscle invasive bladder cancer. (Expert Rev Anticancer Ther, 2015) [PMID:26569509]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Valrubicin. (1999) pubmed
- Valrubicin. (2006) pubmed
- Valrubicin in refractory non-muscle invasive bladder cancer. (2015) pubmed
- Doxorubicin. (2012) pubmed
- Valrubicin-loaded immunoliposomes for specific vesicle-mediated cell death in the treatment of hematological cancers. (2024) pubmed
- Repurposing Valrubicin as a Potent Inhibitor of Ovarian Cancer Cell Growth. (2024) pubmed
- Sequential Intravesical Valrubicin and Docetaxel for the Salvage Treatment of Non-Muscle-Invasive Bladder Cancer. (2022) pubmed
- Valrubicin-loaded immunoliposomes targeting antigens on immunosuppressive cells to circumvent resistance to cancer immunotherapy. (2026) pubmed
- Intravesical valrubicin in the treatment of carcinoma in situ of the bladder. (2001) pubmed
- Extended Outcomes of Intravesical Valrubicin and Docetaxel as a Secondary Salvage Treatment for Recalcitrant High-risk Non-muscle-invasive Bladder Cancer. (2025) pubmed